Partial Pancreatectomy in Adult Humans Does Not Provoke β-Cell Regeneration

OBJECTIVE—β-Cell regeneration has been proposed as a possible treatment for diabetes, but the capacity for new β-cell formation in humans is yet unclear. In young rats, partial pancreatectomy prompts new β-cell formation to restore β-cell mass. We addressed the following questions: In adult humans: 1) Does partial pancreatectomy provoke new β-cell formation and increased β-cell mass? 2) Is β-cell turnover increased after partial pancreatectomy? RESEARCH DESIGN AND METHODS—Protocol 1: human pancreatic tissue was collected from 13 patients who underwent two consecutive partial pancreas resections, and markers of cell turnover were determined in both tissue samples, respectively. Protocol 2: pancreas volumes were determined from abdominal computer tomography scans, performed in 17 patients on two separate occasions after partial pancreatectomy. RESULTS—Protocol 1: fasting glucose concentrations increased significantly after the 50% pancreatectomy (P = 0.01), but the fractional β-cell area of the pancreas remained unchanged (P = 0.11). β-Cell proliferation, the overall replication index (Ki67 staining), and the percentage of duct cells expressing insulin were similar before and after the partial pancreatectomy. The overall frequency of apoptosis (terminal deoxynucleotidyl transferase biotin-dUTP nick-end labeling) was slightly increased following the partial pancreatectomy (P = 0.02). Protocol 2: pancreatic volume was ∼50% reduced to 35.6 ± 2.6 ccm3 by the partial pancreatectomy. The total pancreatic volume was unchanged after an interval of 247 ± 160 days (35.4 ± 2.7 ccm3; P = 0.51). CONCLUSIONS—Unlike in rodents, a 50% pancreatectomy does not prompt β-cell regeneration in adult humans. This explains the high incidence of diabetes after pancreatic resections. Such differences in β-cell turnover between rodents and humans should be born in mind when evaluating new treatment options aiming to restore β-cell mass in patients with diabetes.

[1]  S. Malozowski,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[2]  J. Kushner,et al.  Effects of Autoimmunity and Immune Therapy on β-Cell Turnover in Type 1 Diabetes , 2006, Diabetes.

[3]  J. Leahy,et al.  Regulation of Pancreatic β-Cell Regeneration in the Normoglycemic 60% Partial-Pancreatectomy Mouse , 2006, Diabetes.

[4]  R. Rizza,et al.  Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans , 2006, Diabetologia.

[5]  H. Zhao,et al.  Comment on: Meier JJ, Lin JC, Butler AE, Galasso R, Martinez DS, Butler PC (2006) Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes. Diabetologia 49:1838–1844 , 2006, Diabetologia.

[6]  Kathrin Maedler,et al.  Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1. , 2006, Diabetes.

[7]  P. Butler,et al.  Mechanisms of Impaired Fasting Glucose and Glucose Intolerance Induced by a ∼50% Pancreatectomy , 2006, Diabetes.

[8]  P. Butler,et al.  Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover. , 2006, Diabetes care.

[9]  P. Butler,et al.  Direct evidence of attempted beta cell regeneration in an 89-year-old patient with recent-onset type 1 diabetes , 2006, Diabetologia.

[10]  Johannes D Veldhuis,et al.  Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis. , 2006, Diabetes.

[11]  K. Herold,et al.  Expansion and redifferentiation of adult human pancreatic islet cells. , 2006, Biochemical and biophysical research communications.

[12]  R. Rizza,et al.  Relationship Between β-Cell Mass and Fasting Blood Glucose Concentration in Humans , 2006, Diabetes Care.

[13]  P. Butler,et al.  Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy. , 2006, Diabetes.

[14]  R. Rizza,et al.  Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? , 2005, Diabetologia.

[15]  W. Suarez-Pinzon,et al.  Combination therapy with epidermal growth factor and gastrin increases beta-cell mass and reverses hyperglycemia in diabetic NOD mice. , 2005, Diabetes.

[16]  J. Leahy,et al.  Mechanisms of compensatory beta-cell growth in insulin-resistant rats: roles of Akt kinase. , 2005, Diabetes.

[17]  Michael Stumvoll,et al.  Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.

[18]  M. Nauck,et al.  Glucagon‐like peptide 1(GLP‐1) in biology and pathology , 2005, Diabetes/metabolism research and reviews.

[19]  U. Ribel,et al.  β-Cell function and islet morphology in normal, obese, and obese β-cell mass-reduced Göttingen minipigs , 2005 .

[20]  S. Bonner-Weir,et al.  New sources of pancreatic beta-cells. , 2005, Nature biotechnology.

[21]  U. Ribel,et al.  Beta-cell function and islet morphology in normal, obese, and obese beta-cell mass-reduced Göttingen minipigs. , 2005, American journal of physiology. Endocrinology and metabolism.

[22]  P. Rorsman,et al.  Insulin Secretion , 2004, The Journal of general physiology.

[23]  P. Halban.  Cellular sources of new pancreatic β cells and therapeutic implications for regenerative medicine , 2004, Nature Cell Biology.

[24]  Senta Georgia,et al.  β cell replication is the primary mechanism for maintaining postnatal β cell mass , 2004 .

[25]  Senta Georgia,et al.  Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. , 2004, The Journal of clinical investigation.

[26]  Yuval Dor,et al.  Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. , 2004, Nature.

[27]  M. Oberholzer,et al.  Morphometric evidence for a striking B-cell reduction at the clinical onset of type 1 diabetes , 2004, Virchows Archiv A.

[28]  D. Drucker.  Glucagon-like peptide-1 and the islet beta-cell: augmentation of cell proliferation and inhibition of apoptosis. , 2003, Endocrinology.

[29]  Jae-Hyoung Cho,et al.  Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea , 2003 .

[30]  D. Cowley,et al.  The outcome in Australian children with hyperinsulinism of infancy: early extensive surgery in severe cases lowers risk of diabetes , 2003, Clinical endocrinology.

[31]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[32]  In Kyu Lee,et al.  Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. , 2003, The Journal of clinical endocrinology and metabolism.

[33]  B. Portha,et al.  Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. , 2002, Diabetes.

[34]  H. Joller-jemelka,et al.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.

[35]  J. Leahy,et al.  Enhanced expression of insulin receptor substrate–2 and activation of protein kinase B/Akt in regenerating pancreatic duct epithelium of 60 %-partial pancreatectomy rats , 2001, Diabetologia.

[36]  M. Straume,et al.  Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. , 2001, Diabetes.

[37]  B. Portha,et al.  Impaired β-cell regeneration after partial pancreatectomy in the adult Goto-Kakizaki rat, a spontaneous model of type II diabetes , 2001, Histochemistry and Cell Biology.

[38]  S. Bonner-Weir.  beta-cell turnover: its assessment and implications. , 2001, Diabetes.

[39]  J. Klempnauer,et al.  Guanylin in the human pancreas: a novel luminocrine regulatory pathway of electrolyte secretion via cGMP and CFTR in the ductal system , 2001, Histochemistry and Cell Biology.

[40]  B. Portha,et al.  Impaired beta-cell regeneration after partial pancreatectomy in the adult Goto-Kakizaki rat, a spontaneous model of type II diabetes. , 2001, Histochemistry and cell biology.

[41]  B. Glaser,et al.  Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. , 2000, Diabetes.

[42]  C. Rhodes,et al.  IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication. , 2000, Journal of molecular endocrinology.

[43]  C. Junien,et al.  Clinical features of 52 neonates with hyperinsulinism. , 1999, The New England journal of medicine.

[44]  A. Møldrup,et al.  Beta cell proliferation and growth factors , 1999, Journal of Molecular Medicine.

[45]  L. Bouwens,et al.  Extra-insular beta cells associated with ductules are frequent in adult human pancreas , 1998, Diabetologia.

[46]  L. Baxter,et al.  A Second Pathway for Regeneration of Adult Exocrine and Endocrine Pancreas: A Possible Recapitulation of Embryonic Development , 1993, Diabetes.

[47]  J. Najarian,et al.  Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. , 1990, The New England journal of medicine.

[48]  J. Leahy,et al.  Compensatory adaption to partial pancreatectomy in the rat. , 1989, Endocrinology.

[49]  R. Klapdor,et al.  Increase in B-cells in the pancreatic remnant after partial pancreatectomy in pigs , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[50]  F. Marincola,et al.  Accommodation to a reduced islet cell mass in dogs. , 1984, The American journal of physiology.

[51]  L. Aerts,et al.  A MORPHOLOGICAL STUDY OF THE ENDOCRINE PANCREAS IN HUMAN PREGNANCY , 1978, British journal of obstetrics and gynaecology.

[52]  K. Pearson,et al.  Effects of partial surgical pancreatectomy in rats. I. Pancreatic regeneration. , 1977, Gastroenterology.